Bionano Genomics (BNGO) Other financing activities (2020 - 2026)

Bionano Genomics has disclosed Other financing activities across 7 years of filings, most recently posting $28000.0 for Q1 2026.

• Other financing activities for Q1 2026 came in at $28000.0, down 96.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 46.01% YoY), and the FY2025 annual result was $2.1 million, up 21.47% from the prior year.
• Other financing activities came in at $28000.0 for Q1 2026 at Bionano Genomics, down from $2.1 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $2.1 million in Q4 2025 to a low of -$1.0 million in Q3 2025.
• The 5-year median for Other financing activities is $352000.0 (2023), against an average of $422785.7.
• Peak annual rise in Other financing activities reached 600.33% in 2025, while the deepest fall reached 1347.56% in 2025.
• Bionano Genomics' Other financing activities stood at $578000.0 in 2022, then sank by 51.04% to $283000.0 in 2023, then advanced by 7.07% to $303000.0 in 2024, then surged by 600.33% to $2.1 million in 2025, then plunged by 98.68% to $28000.0 in 2026.
• The last three Other financing activities figures came in at $28000.0 (Q1 2026), $2.1 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.